Publications by authors named "Ronald Pedersen"

Claim this Profile
P
Predictors of response to etanercept-methotrexate treatment: a post hoc logistic regression analysis of a randomized, open-label study in Latin American patients with rheumatoid arthritis.
Maria de la Vega, Generoso Guerra Bautista, Ricardo Machado Xavier, César Pacheco-Tena, Gastón Solano, Ronald D Pedersen

Adv Rheumatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
Gary R Lichtenstein, Gerhard Rogler, Matthew A Ciorba, Chinyu Su, Gary Chan, Ronald D Pedersen

Inflamm Bowel Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis.
Bruce E Sands, Pam R Taub, Alessandro Armuzzi, Gary S Friedman, Michele Moscariello, Ronald D Pedersen

Clin Gastroenterol Hepatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of flare on radiographic progression after etanercept continuation, tapering or withdrawal in patients with rheumatoid arthritis.
Josef S Smolen, Ronald Pedersen, Heather Jones, Ehab Mahgoub, Lisa Marshall

Rheumatology (Oxford)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis.
Generoso Guerra Bautista, Ricardo Machado Xavier, Maria de la Vega, J Abraham Simón-Campos, Gastón Solano, Ronald D Pedersen

Open Access Rheumatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials.
Christopher J Edwards, Katherine Roshak, Jack F Bukowski, Ronald Pedersen, Mazhar Thakur

Drugs Aging· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial.
Ivan Foeldvari, Tamàs Constantin, Jelena Vojinović, Gerd Horneff, Vyacheslav Chasnyk, Ronald D Pedersen

Arthritis Res Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
Kevin L Winthrop, Gil Y Melmed, Séverine Vermeire, Millie D Long, Gary Chan, Ronald D Pedersen

Inflamm Bowel Dis· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Karel Pavelka, Nurullah Akkoç, Mustafa Al-Maini, Cristiano A F Zerbini, Dmitry E Karateev, Ronald Pedersen

Rheumatol Int· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study.
Wei Zhang, Nick Bansback, Huiying Sun, Ronald Pedersen, Sameer Kotak

RMD Open· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region.
Daniel A Machado, Renato Guzman, Ricardo M Xavier, Jesus A Simon, Linda Mele, Ronald Pedersen

Open Rheumatol J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study.
Wei Zhang, Nick Bansback, Huiying Sun, Ronald Pedersen, Sameer Kotak

RMD Open· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
Roy Fleischmann, Désirée van der Heijde, Andrew S Koenig, Ronald Pedersen, Annette Szumski

Ann Rheum Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment.
Lluís Puig, Robert Strohal, Joanne Fuiman, Ronald Pedersen, Annette Szumski

J Dermatolog Treat· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained remission with etanercept tapering in early rheumatoid arthritis.
Paul Emery, Mohammed Hammoudeh, Oliver FitzGerald, Bernard Combe, Emilio Martin-Mola, Ronald Pedersen

N Engl J Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment.
Robert L Boggs, Sarolta Kárpáti, Wenzhi Li, Theresa Williams, Ronald Pedersen

BMC Dermatol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the PASE questionnaire, psoriatic arthritis (PsA) prevalence and PsA improvement with anti-TNF therapy: results from the PRISTINE trial.
M Elaine Husni, Abrar A Qureshi, Andrew S Koenig, Ronald Pedersen, Deborah Robertson

J Dermatolog Treat· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.
Susan G Kornstein, Ronald D Pedersen, Peter J Holland, Charles B Nemeroff, Anthony J Rothschild

J Clin Psychiatry· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
Daniel A Machado, Renato M Guzman, Ricardo M Xavier, J Abraham Simon, Linda Mele, Ronald Pedersen

J Clin Rheumatol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A factor analysis of posttraumatic stress disorder symptoms using data pooled from two venlafaxine extended-release clinical trials.
Dan J Stein, Barbara O Rothbaum, David S Baldwin, Annette Szumski, Ronald Pedersen

Brain Behav· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial).
Robert Strohal, Luis Puig, Edgardo Chouela, Tsen-Fang Tsai, Jeffrey Melin, Ronald Pedersen

J Dermatolog Treat· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
Josef S Smolen, Peter Nash, Patrick Durez, Stephen Hall, Elena Ilivanova, Ronald Pedersen

Lancet· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
Désirée van der Heijde, Jürgen Braun, Maxime Dougados, Joachim Sieper, Ronald Pedersen

Rheumatology (Oxford)· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study.
Paul Emery, Tore K Kvien, Bernard Combe, Bruce Freundlich, Deborah Robertson, Ronald Pedersen

Ann Rheum Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial.
Niels Qvist, Brian Warren, Heidi Leister-Tebbe, Edward T Zito, Ronald Pedersen

Surg Infect (Larchmt)· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis